Eur J Cancer 2009.Interim 18-FDGPET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP .Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse l ......